BrainStorm Cell Therapeutics (NASDAQ:BCLI) CMO Dr. Ralph Kern sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.
BrainStorm Cell Therapeutics halfway through enrolling its Phase 3 ALS study
Upcoming Events
07/11-13/22
07/20/22
11/07-09/22
01/09-11/23
01/09-11/23
01/09-11/23
06/12-14/23